Table 3.

SF-8 scores of the entire treated population before treatment and at 1, 3, and 6 months after BAE and comparison of the pre-treatment scores and those at 1, 3, and 6 months after BAE, as well as fractional changes in the score at 6 months after BAE divided by the baseline score and multiplied by 100

	SF-8 mean (SD)				p			Change in scores (%) from baseline to 6 months
Total, n = 61	Before treatment	1 month after BAE	3 months after BAE	6 months after BAE	Before vs. 1 month	Before vs. 3 months	Before vs. 6 months
Physical component score	42.81 (9.28)	47.39 (7.45)	47.21 (7.23)	45.29 (8.04)	< 0.001	0.003	0.058	9.5
Physical functioning	40.33 (11.61)	45.76 (9.13)	45.40 (9.05)	43.58 (9.97)	< 0.001	0.008	0.035	15.2
Role physical	41.68 (11.12)	46.31 (8.52)	45.45 (9.45)	42.90 (10.50)	0.002	0.092	0.647	8.1
Bodily pain	51.07 (9.70)	52.96 (7.82)	54.25 (6.81)	53.69 (7.84)	0.171	0.036	0.059	9.3
General health	43.00 (7.31)	50.53 (7.30)	49.53 (6.96)	48.55 (7.74)	< 0.001	< 0.001	< 0.001	15.63
Mental component score	43.18 (9.40)	46.85 (7.51)	46.91 (8.04)	47.37 (8.30)	0.027	0.023	0.002	14.14
Vitality	44.74 (7.32)	49.10 (6.83)	48.86 (6.90)	49.29 (7.32)	0.001	0.007	0.001	12.25
Social functioning	41.81 (11.13)	44.12 (10.26)	45.41 (11.28)	44.69 (10.26)	0.121	0.061	0.059	10.58
Role emotional	41.44 (11.37)	46.09 (7.89)	45.95 (9.01)	45.93 (9.31)	0.001	0.002	0.001	17.89
Mental health	45.43 (9.51)	49.99 (7.29)	49.59 (7.36)	49.06 (8.42)	0.005	0.022	0.013	12.13

BAE, bronchial artery embolisation; SD, standard deviation